The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...

The AstraZeneca PLC ADR AZN rose 1.25% to $68.81 Friday, on what proved to be an all-around positive trading session for the ...

Scientists report that they have learned how certain combinations of rearranged genes can promote the progression of a rare type of kidney cancer.

On May 8, 2025, the Court of Appeals for the Third Circuit affirmed the district court’s dismissal of AstraZeneca’s challenges to the ...

Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

A significant number of patients taking Bruton tyrosine kinase inhibitors (BTKis) for chronic lymphocytic leukemia (CLL) develop atrial fibrillation (AF).

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

Mereo BioPharma Group plc’s MREO share price has dipped by 5.63%, which has investors questioning if this is right time to ...

The AstraZeneca PLC ADR AZN slipped 2.20% to $66.23 Wednesday, on what proved to be an all-around mixed trading session for ...